AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 38 filers reported holding AQUINOX PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $29,000 | -12.1% | 12,153 | 0.0% | 0.00% | – |
| Q1 2019 | $33,000 | +26.9% | 12,153 | 0.0% | 0.00% | – |
| Q4 2018 | $26,000 | -73.5% | 12,153 | -63.6% | 0.00% | – |
| Q3 2018 | $98,000 | +16.7% | 33,401 | +4.9% | 0.00% | – |
| Q2 2018 | $84,000 | -77.0% | 31,838 | +22.5% | 0.00% | – |
| Q1 2018 | $366,000 | +46.4% | 25,984 | +22.5% | 0.00% | – |
| Q4 2017 | $250,000 | +29.5% | 21,210 | +55.4% | 0.00% | – |
| Q3 2017 | $193,000 | +17.7% | 13,653 | +16.7% | 0.00% | – |
| Q2 2017 | $164,000 | -15.9% | 11,700 | 0.0% | 0.00% | – |
| Q1 2017 | $195,000 | +3.7% | 11,700 | +2.6% | 0.00% | – |
| Q4 2016 | $188,000 | +22.9% | 11,400 | 0.0% | 0.00% | – |
| Q3 2016 | $153,000 | +96.2% | 11,400 | -4.2% | 0.00% | – |
| Q2 2016 | $78,000 | – | 11,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 877,753 | $11,727,000 | 5.26% |
| RA Capital Management | 2,191,977 | $29,285,000 | 3.02% |
| NEXTHERA CAPITAL LP | 340,000 | $4,542,000 | 2.79% |
| Opaleye Management Inc. | 310,000 | $4,142,000 | 2.17% |
| Baker Brothers Advisors | 10,536,092 | $140,762,000 | 1.28% |
| Ghost Tree Capital, LLC | 250,000 | $3,340,000 | 0.54% |
| Cormorant Asset Management, LP | 151,838 | $2,029,000 | 0.22% |
| DAFNA Capital Management LLC | 20,000 | $267,000 | 0.19% |
| ELLINGTON MANAGEMENT GROUP LLC | 10,800 | $144,000 | 0.04% |
| Alyeska Investment Group, L.P. | 272,163 | $3,636,000 | 0.03% |